Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-05

FDA Approved: XANAX XR — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved a supplemental application for XANAX XR (alprazolam) from Viatris Specialty LLC. The action involves changes to the product labeling as part of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XANAX XR (alprazolam)

Snippet

SUPPL AP for XANAX XR (ALPRAZOLAM)